Biond Biologics
Latest round
- Series C
Last raised
- Nov 2021
Total raised
- $32M
Investors
- 6
About Biond Biologics
Biond Biologics Ltd.Founded in 2016 and headquartered in Nahariyya, Israel, Biond Biologics specializes in the creation of groundbreaking biologics aimed at treating various cancers.Biond Biologics specializes in the development of innovative therapies aimed at addressing various forms of cancer. The company's core offerings focus on breakthrough biologics that utilize advanced biotechnology to target and combat cancerous cells, thereby enhancing treatment efficacy and minimizing side effects. These products are designed for use in clinical settings and are intended for oncologists, healthcare providers, and hospitals that are looking for cutting-edge treatment options for their patients.Biond Biologics operates on a revenue model that primarily involves partnerships with healthcare institutions and pharmaceutical companies for the distribution and application of its therapeutic products. Revenue is generated through direct sales to hospitals and clinics, as well as potential licensing agreements that facilitate the use of Biond's innovative therapies in broader healthcare settings. The pricing structure typically reflects the advanced nature of the products, with flagship offerings commanding premium pricing in line with their unique therapeutic capabilities. The company is also seeking to expand its presence in emerging markets in Asia and South America by 2023, enhancing distribution and partnerships in these regions.
Who invested in Biond Biologics
6 investors across 2 rounds
See all investors in Biond Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biond Biologics
Who invested in Biond Biologics?
Biond Biologics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biond Biologics raised?
Biond Biologics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biond Biologics last raise money?
Biond Biologics's most recent round on record is a Series C, in Nov 2021.
What does Biond Biologics do?
Biond Biologics is a biotechnology company.
Where is Biond Biologics headquartered?
Biond Biologics is headquartered in Nahariyya, Israel.
Which VCs invest in companies like Biond Biologics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Biond Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Biond Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.